Cargando…
Oncologic Outcome and Immune Responses of Radiotherapy with Anti-PD-1 Treatment for Brain Metastases Regarding Timing and Benefiting Subgroups
SIMPLE SUMMARY: Immune checkpoint inhibitors (ICIs) and radiotherapy (RT) are widely used for patients with brain metastasis (BM). To evaluate markers for treatment response and find a treatment concept which has the best outcome effects, we analyzed data of 93 patients with BM from different cancer...
Autores principales: | Trommer, Maike, Adams, Anne, Celik, Eren, Fan, Jiaqi, Funken, Dominik, Herter, Jan M., Linde, Philipp, Morgenthaler, Janis, Wegen, Simone, Mauch, Cornelia, Franklin, Cindy, Galldiks, Norbert, Werner, Jan-Michael, Kocher, Martin, Rueß, Daniel, Ruge, Maximilian, Meißner, Anna-Katharina, Baues, Christian, Marnitz, Simone |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8909717/ https://www.ncbi.nlm.nih.gov/pubmed/35267546 http://dx.doi.org/10.3390/cancers14051240 |
Ejemplares similares
-
Addition of Radiotherapy to Immunotherapy: Effects on Outcome of Different Subgroups Using a Propensity Score Matching
por: Trommer, Maike, et al.
Publicado: (2020) -
Robotic Stereotactic Radiosurgery in Melanoma Patients with Brain Metastases under Simultaneous Anti-PD-1 Treatment
por: Trommer-Nestler, Maike, et al.
Publicado: (2018) -
The Role of Age and Comorbidities in Esophagogastric Cancer Chemoradiation of the Frail Elderly (>70 Years): An Analysis from a Tertiary High Volume-Center
por: Linde, Philipp, et al.
Publicado: (2022) -
Chemoradiation for elderly patients (≥ 65 years) with esophageal cancer: a retrospective single-center analysis
por: Linde, Philipp, et al.
Publicado: (2022) -
Abscopal Effects in Radio-Immunotherapy—Response Analysis of Metastatic Cancer Patients With Progressive Disease Under Anti-PD-1 Immune Checkpoint Inhibition
por: Trommer, Maike, et al.
Publicado: (2019)